Table:
begin	end	state
1	14	cytoplasmic
15	34	transmembrane
35	56	non-cytoplasmic
57	78	transmembrane
79	84	cytoplasmic
85	104	transmembrane
105	109	non-cytoplasmic
110	127	transmembrane
128	147	cytoplasmic
148	170	transmembrane
171	199	non-cytoplasmic
200	219	transmembrane
220	252	cytoplasmic
253	275	transmembrane
276	294	non-cytoplasmic
295	314	transmembrane
315	320	cytoplasmic
321	338	transmembrane
339	343	non-cytoplasmic
344	367	transmembrane
368	376	cytoplasmic
377	398	transmembrane
399	407	non-cytoplasmic
408	429	transmembrane
430	439	cytoplasmic

Input:
>WP_009124055.1 NCBI__GCF_000195635.1:WP_009124055.1
MNNIKKTTIMSKDGVSYLIPFILITSCFALWGFANDITNPMVKAFSKIFRMSVTDGALVQ
VAFYGGYFAMAFPAAMFIRKYSYKAGVLLGLGLYALGAFLFFPAMLTGSYYPFLIAYFVL
TCGLSFLETSSNPYILSMGTEETATRRLNLAQSFNPMGSLLGMYVAMNFIQNRLNPMDTV
ERSQLAAADFEAVRDSDLSVLIGPYLVIGIIVLLMLFLIRMVKMPKNADQSHEIDFFPTL
KRIFRIKHYREGVIAQFFYVGAQIMCWTFIIQYGTRLFMADGMEEKAAEVLSQEYNIIAM
IIFCCSRFICTFILRYLSPGLLLKVLAIVACLLTGGVIGFQNIWGMYCLVGVSACMSLMF
PTIYGIALQGLGDDAKFGAAGLIMAILGGSVLPPLQASIIDQHTLLGMPAVNLSFILPLI
CFVVITIYGHRSYVRQKCK

Or try the official Phobius web server, which has a different display

Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server